Mar 10, 2026 05:00PM CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth

Feb 26, 2026 08:30AM CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness

Dec 22, 2025 07:00PM CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

Nov 13, 2025 06:20PM CV Sciences (CVSI) Reports Q3 EPS of $0.00

Nov 13, 2025 04:00PM CV Sciences, Inc. Reports Third Quarter 2025 Financial Results

Nov 10, 2025 06:15PM CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

Aug 26, 2025 09:00PM CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus

Aug 13, 2025 06:29PM CV Sciences (CVSI) Reports Q2 EPS of $0.00

Aug 13, 2025 04:00PM CV Sciences, Inc. Reports Second Quarter 2025 Financial Results

Aug 8, 2025 05:00PM CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025

Jun 23, 2025 08:00PM CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3

May 14, 2025 06:38PM CV Sciences (CVSI) Reports Q1 EPS of $0.00

May 14, 2025 04:00PM CV Sciences, Inc. Reports First Quarter 2025 Financial Results

May 9, 2025 06:30PM CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025

Mar 27, 2025 09:00AM CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results

Mar 26, 2025 04:33PM CV Sciences (CVSI) launches Lunar Fox Food line of plant-based foods

Mar 26, 2025 04:30PM CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods

Mar 20, 2025 04:30PM CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025

Feb 5, 2025 09:00AM CV Sciences Unveils New Aura Collection THC Fizz Tablets

Nov 21, 2024 04:34PM CV Sciences (CVSI) to Acquire Extract Labs

Nov 14, 2024 04:44PM CV Sciences (CVSI) Reports Q3 EPS of $0.00

Aug 13, 2024 09:05AM CV Sciences (CVSI) Reports Q2 EPS of $0.00